All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Intra-Cellular Therapies, Inc. market cap

Intra-Cellular Therapies, Inc. volume of trade today and historical data of Intra-Cellular Therapies, Inc. capitalization since start date of trade of ITCI stocks.
Add to widgets
Added to widgets

Intra-Cellular Therapies, Inc. capitalization

Today's market capitalization for Intra-Cellular Therapies, Inc. is 5 791 083 520 US dollar.
-287 780 352 $ (-4.73%)
change of capitalization since yesterday

Intra-Cellular Therapies, Inc. market capitalization is the sum of all Intra-Cellular Therapies, Inc. stock quotes issued. Our website takes information of Intra-Cellular Therapies, Inc. capitalization for today from open sources. You can find out the Intra-Cellular Therapies, Inc. capitalization for today based on the trading of this stock quote on stock exchange market. Intra-Cellular Therapies, Inc. market cap decreased by $ -287 780 352.

Intra-Cellular Therapies, Inc. volume of trade

Today's Intra-Cellular Therapies, Inc. volume of trade is 51 532 US dollar.
-394 006 $ (-88.43%)
change of volume of trade since yesterday

Today, Intra-Cellular Therapies, Inc. trading took place on various stocks markets. The daily chart of the Intra-Cellular Therapies, Inc. trading volume is presented on our website. Intra-Cellular Therapies, Inc. trading helds on many stock quote exchanges in real time, we show the daily trading volume of Intra-Cellular Therapies, Inc.. Intra-Cellular Therapies, Inc. market cap is going down.

Show:
to

Intra-Cellular Therapies, Inc. market cap chart

Intra-Cellular Therapies, Inc. capitalization on a graph by years. Over the week, Intra-Cellular Therapies, Inc. capitalization has changed by -0.23%. 11.18% per year - a change in the market capitalization of Intra-Cellular Therapies, Inc.. Today, Intra-Cellular Therapies, Inc. capitalization is equal to 5 791 083 520 US dollars.

Week Month 3 months Year 3 years

Intra-Cellular Therapies, Inc. capitalization history

Date Capitalization
Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
04/05/2023 5 791 083 520 $
03/05/2023 6 078 863 872 $
02/05/2023 6 189 864 960 $
01/05/2023 6 037 893 632 $
28/04/2023 5 975 961 600 $
27/04/2023 5 807 077 888 $
26/04/2023 5 804 696 064 $

Intra-Cellular Therapies, Inc. volume chart

Week Month 3 months Year 3 years

Intra-Cellular Therapies, Inc. volume history data

Date Volume (24h)
Volume of trade of Intra-Cellular Therapies, Inc. - total sum in US dollars for all deals with ITCI stocks bought and sold during selected date.
04/05/2023 51 532 $
03/05/2023 445 538 $
02/05/2023 373 951 $
01/05/2023 1 465 289 $
28/04/2023 295 084 $
27/04/2023 17 590 $
26/04/2023 699 423 $

Intra-Cellular Therapies, Inc. capitalization is equal to 5 791 083 520 US dollars at 04/05/2023. 03/05/2023 Intra-Cellular Therapies, Inc. capitalization is equal to 6 078 863 872 US dollars. Intra-Cellular Therapies, Inc. capitalization at 02/05/2023 amounted to 6 189 864 960 US dollars. Intra-Cellular Therapies, Inc. capitalization at 01/05/2023 amounted to 6 037 893 632 US dollars.

Intra-Cellular Therapies, Inc. capitalization at 28/04/2023 is equal to 5 975 961 600 US dollars. 27/04/2023 Intra-Cellular Therapies, Inc. capitalization amounted to 5 807 077 888 US dollars. The market capitalization of Intra-Cellular Therapies, Inc. at 26/04/2023 amounted to 5 804 696 064 US dollars.

Intra-Cellular Therapies, Inc. capitalization is 5 791 083 520 $ now. Market capitalization of Intra-Cellular Therapies, Inc. changed by -4.734% since yesterday. Today's volume of trade of ITCI stocks was 51 532 $. ITCI volume of trade amount changed to -88.434% since yesterday.

Intra-Cellular Therapies, Inc. stocks data

Intra-Cellular Therapies, Inc. financials